Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PRRX2 | hg38_v1_chr9_+_129665603_129665672 | -0.33 | 6.2e-02 | Click! |
HOXB6 | hg38_v1_chr17_-_48604959_48605000 | -0.26 | 1.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_7332744 Show fit | 21.63 |
ENST00000436368.6
ENST00000311745.9 ENST00000340209.8 ENST00000620507.4 |
RNA binding fox-1 homolog 1 |
|
chr12_-_16608183 Show fit | 19.79 |
ENST00000354662.5
ENST00000538051.5 |
LIM domain only 3 |
|
chr12_-_16608073 Show fit | 19.47 |
ENST00000441439.6
|
LIM domain only 3 |
|
chr2_-_49974182 Show fit | 18.38 |
ENST00000412315.5
ENST00000378262.7 |
neurexin 1 |
|
chr2_-_49974155 Show fit | 18.07 |
ENST00000635519.1
|
neurexin 1 |
|
chr7_+_107470050 Show fit | 16.63 |
ENST00000304402.6
|
G protein-coupled receptor 22 |
|
chr2_+_161416273 Show fit | 16.08 |
ENST00000389554.8
|
T-box brain transcription factor 1 |
|
chr16_+_7303245 Show fit | 14.91 |
ENST00000674626.1
|
RNA binding fox-1 homolog 1 |
|
chr5_-_88824266 Show fit | 14.73 |
ENST00000509373.1
ENST00000636541.1 |
myocyte enhancer factor 2C |
|
chr4_-_175812236 Show fit | 13.59 |
ENST00000505375.5
|
glycoprotein M6A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 79.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.6 | 57.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.0 | 57.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
5.0 | 55.2 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
3.6 | 54.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.6 | 52.6 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.8 | 35.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.6 | 35.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.5 | 34.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 30.9 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 137.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 100.7 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 83.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.5 | 82.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.4 | 62.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.3 | 56.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.6 | 43.8 | GO:0031430 | M band(GO:0031430) |
0.2 | 38.1 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 37.5 | GO:0045202 | synapse(GO:0045202) |
0.5 | 34.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 99.8 | GO:0044325 | ion channel binding(GO:0044325) |
0.4 | 68.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 62.9 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.2 | 59.9 | GO:0005516 | calmodulin binding(GO:0005516) |
2.4 | 55.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 51.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.6 | 51.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 42.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 35.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.8 | 33.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 71.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 29.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 27.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 27.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 26.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 22.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 19.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 15.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 13.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 10.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 87.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.4 | 63.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 44.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.1 | 33.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.6 | 33.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 31.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 26.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 25.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 25.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 25.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |